MPTs: Articles
from the Field

Issue #27 - 19 August 2016
 

 

Dear Colleagues,

 

The Multipurpose Prevention Technologies (MPTs) field is steadily evolving and expanding. Provided below are links to recent publications, media articles, and other resources relevant to MPTs to keep you up-to-date. Please note that contents are neither endorsed by nor necessarily represent the views of the Initiative for Multipurpose Prevention Technologies (IMPT), and that due to publication copyright and permissions restrictions, full-text versions of resources may not be publicly available.

 

If you have a resource to include in our next issue, please send to Vanetta Thomas at vthomas@cami-health.org. Previous issues are available on the IMPT website.     

 

Best,

 

IMPT Secretariat Staff

Journal Articles

A First-in-Human Trial of MIV-150 and Zinc Acetate Co-Formulated in a Carrageenan Gel: Safety, Pharmacokinetics, Acceptability, Adherence and Pharmacodynamics . Friedland, B,A., Hoesley, C.J., Plagianos, M., Hoskin, E., Zhang, S., Teleshova, N., ...Creasy, G. (2016, July). Journal of Acquired Immune Deficiency Syndromes.
 
A Novel Microbicide/Contraceptive Intravaginal Ring Protects Macaque Genital Mucosa against SHIV-RT Infection Ex Vivo. Villegas, G., Calenda, G., Ugaonkar, S., Zhang, S., Kizima, L, Mizenina, O., ... Zydowsky, T.M. (2016, July). PLOS One.
 
Abolishing HIV-1 infectivity using a polypurine tract-specific G-quadruplex forming oligonucleotide. Voges, M., Schneider, C., Sinn, M., Hartig, J.S., Reimer, R., Hauber, J., & Moelling, K. (2016, July). BMC Infectious Diseases.
 
Characteristics of women screened for a contraceptive intravaginal ring study in Kisumu, Kenya, 2014. McLellan-Lemal, E., Gust, D.A., Gvetadze, R., Furtado, M., Otieno, F.O., Desai, M., ...Makanga, E.M. (2016, July). Research Journal of Women's Health.  
 
HIV pre-exposure prophylaxis for women. (Sheth, A.N., Rolle, C.P., Gandhi, M). (2016, July). Journal of Virus Eradication, 2(3), 149-155.

In vitro exposure to PC-1005 and cervicovaginal lavages from women vaginally administered PC-1005 inhibit HIV-1 and HSV-2 infection in human cervical mucosa. Villegas, G., Calenda, G., Zhang, S., Mizenina, O., Kleinbeck, K., Cooney, M.L., ... Teleshova, N. (2016, July). Antimicrobial Agents and Chemotherapy.
 
Matrix and reservoir-type multipurpose vaginal rings for controlled release of dapivirine and levonorgestrel. Boyd, P., Fetherston, S.M., McCoy, C.F., Major, I., Murphy, D.J., Kumar, S., Holt, J., ... Malcolm, R.K. (2016, September). International Journal of Pharmaceutics, 511(1), 619-629.
 
Microbicide vaginal rings: Technological challenges and clinical development . Malcolm, R.K., Boyd, P.J., McCoy, C.F., Murphy, D.J. (2016, August). Advanced Drug Delivery Reviews, volume 103, 33-56.

Pipeline for contraceptive development Blithe, D.L. (2016). Fertility and Sterility. 

Planning for HIV preexposure prophylaxis introduction: lessons learned from contraception. Delany-Moretlwe, S., Mullick, S., Eakle, R., Rees, H. (2016, January). Current Opinion in HIV and AIDS, 11(1), 87-93.
 
Trichomoniasis - are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide? Menezes, C.B., Frasson, A.P., Tasca, T. (2016, June). Microbial Cell: Special Issue on Sexually Transmitted Infections.  

Media Articles


Make full SRHR for young women a priority. Boonstra, Heather. (2016, July 16). Sex Rights Africa Network.    
 
Meet the ASU Researcher Who's Building a Better Condom . Hogan, S. (2016, August 4). Phoenix New Times.  

The search for answers to hormonal contraception's role in HIV infection . Cherpes, T.L. (2016, July 21). The Conversation.  

Reports

2016 Pipeline Report. HIV and TB. Drugs, Diagnostics, Vaccines, Preventive Technologies, Research Toward a Cure, and Immune-Based and Gene Therapies in Development. Clayden, P., Collins, S., Frick, M., Harrington, M., Horn, T., Jefferys, R., Lessem, E., & McKenna, L. (2016, July 15).
  
Big Data Real People . (2016, July). AVAC. 

In the Blogosphere


What women want (in HIV protection). Anderson, L. (2016, July 15). PATH. 

Press Releases

Visit www.MPTs101.org and www.theIMPT.org
for more resources on MPTs.


Facebook    Twitter

IMPT Secretariat

308 Natoma Street, Suite 150
Folsom, CA 95630
+1-916-932-4785
IMPT@cami-health.org
www.theIMPT.org
www.MPTs101.org